Clinical trial · Interventional
Oncometabolic Surgery
Comparison of the Long-limb vs. Conventional Roux-en-Y Reconstruction After Distal Gastrectomy in Gastric Cancer Patients With Type II Diabetes(Multicenter Prospective Randomized Controlled Study)
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Recently, the concept of "Onco-metabolic surgery" has emerged, and it is a theory that if anastomosis bypassing the duodenum and upper jejunum is performed after gastrectomy in gastric cancer patients with type 2 diabetes, diabetes can be expected to improve. The authors would like to compare and analyze the effect of long bowel Luwai gastrointestinal anastomosis in gastric cancer patients with type 2 diabetes in a multicenter prospective manner with that of type 2 diabetes gastric cancer patients who underwent a conventional Luwai gastrointestinal anastomosis.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Gastric Cancer | Malignant Gastric Neoplasm | CURATED_BROADER | 0.80 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| long-limb Roux-en-Y gastrojejunostomy | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- ACTIVE_COMPARATOR
- label
- Multicenter Prospective Randomized Controlled Study
- description
- * Before the start of surgery, the study group and the control group are selected by random assignment and the surgery is performed. * The target groups that met the criteria for selection of the study are randomly divided into two groups (study group: long bowel Luwai anastomosis group, and control group: existing Luwai anastomosis group). The assignment of the two groups is to contact the institution to which the entire clinical trial director belongs, that is, the research nurse at Korea University Guro Hospital, to receive a military assignment after the subject of the study is registered for each institution and before surgery.
- interventionNames
- Procedure: long-limb Roux-en-Y gastrojejunostomy
Primary outcomes (1)
- measure
- 1)Primary Endpoint
- timeFrame
- one year after surgery.
- description
- Rate of more than improvement in diabetic control \- HbA1c \<6.5%, FBS 125 mg/dL \& not increase in antidiabetic medication requirement
Secondary outcomes (1)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 20 Years
- Maximum age
- 79 Years
Show eligibility criteria text
Inclusion Criteria: * Clinical Stage I Gastric Cancer * a patient aged 20 to 80 * Dx of Type 2 Diabetes * Preoperative BMI ≥ 23 kg/m2 Exclusion Criteria: * If you have a history of cancer other than gastric cancer in the last five years * If you received chemotherapy treatment before gastric cancer surgery * Preoperative advanced gastric cancer is diagnosed, or gastric total resection is performed in the upper part * If you have a history of malabsorption
References
Publications (0)
Data not yet available